股 票 研 究 公 司 更 新 报 告 证 券 研 究 报 告 国泰君安版权所有发送给上海东方财富金融数据服务有限公司.东财接收研报邮箱.ybjieshou@eastmoney.com p1 长江电力 2024 年三季报点评 水电主业量价齐升，投资收益稳健增长 长江电力(600900) [Table_Industry] 电力/公用事业 | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |----------|-------------------------------------|----------------------------|-------|--------|----------------|-------|-------|-------|-------------------------|-------| | | | | | | | | | | | | | | [table_Authors] 于鸿光 ( 分析师 ) | 孙辉贤 ( 分析师 ) | | 汪玥 ( | 研究助理 | ) | | | | | | | ...

Investment Rating - Maintains an "Overweight" rating [2][3] - Target price raised to 71.82 RMB (previously 52.96 RMB) [2][3] Core Views - Strong growth in backlog, with TIDES business contributing significantly to future growth [2] - Revenue for 2024 Q1-Q3 was 27.702 billion RMB (-6.23% YoY), with net profit attributable to shareholders at 6.533 billion RMB (-19.11% YoY) [2] - Q3 revenue was 10.461 billion RMB (-1.96% YoY), with net profit attributable to shareholders at 2.293 billion RMB (-17.02% YoY) [2] - EPS forecasts for 2024-2026 adjusted to 3.34/3.78/4.27 RMB, reflecting improved profitability from cost reductions and capacity utilization [2] Business Performance - Chemical business revenue grew 10.4% YoY in 2024 Q1-Q3, excluding COVID-related commercial orders [2] - Testing business revenue declined 4.9% YoY, with clinical CRO and SMO revenue growing 3.4% and 16% respectively [2] - Biology business revenue declined 3.6% YoY, but new molecule types grew 6.0% [2] - High-end therapy CTDMO business revenue declined 17.0% YoY due to early-stage commercialization and project delays [2] - Backlog as of 2024 Q3 reached 43.82 billion RMB, up 35.2% YoY, with revenue from top 20 global pharmaceutical companies at 11.22 billion RMB [2] TIDES Business - TIDES business revenue grew 71.0% YoY in 2024 Q1-Q3, reaching 3.55 billion RMB [2] - Backlog for TIDES business increased 196% YoY, with D&M service customers growing 20% and molecules served growing 22% [2] - Capacity expansion expected, with solid-phase synthesis reactor volume projected to reach 41,000L by end of 2024 [2] Financial Summary - 2024E revenue forecast at 39.459 billion RMB (-2.2% YoY), with net profit attributable to shareholders at 9.638 billion RMB (+0.3% YoY) [8] - 2025E revenue forecast at 44.451 billion RMB (+12.7% YoY), with net profit attributable to shareholders at 10.905 billion RMB (+13.1% YoY) [8] - 2026E revenue forecast at 49.858 billion RMB (+12.2% YoY), with net profit attributable to shareholders at 12.336 billion RMB (+13.1% YoY) [8] - ROE expected to remain stable at around 16.3%-16.4% from 2024E to 2026E [8] Valuation and Market Data - Current price at 52.00 RMB, with a 52-week range of 36.87-90.88 RMB [4] - Market capitalization at 150.176 billion RMB, with 2.888 billion total shares and 2.501 billion A-shares outstanding [4] - P/E ratio for 2024E at 15.58x, with P/B ratio at 2.55x [8] Industry Comparison - Comparable companies include WuXi Biologics (2269 HK) with a 2024E P/E of 18.85x and Pharmaron (300759 SZ) with a 2024E P/E of 30.25x [10] - Average P/E for comparable companies in 2024E is 22.4x [10]

国泰君安版权所有发送给上海东方财富金融数据服务有限公司.东财接收研报邮箱.ybjieshou@eastmoney.com p1 股 票 研 究 股票研究 /[Table_Date] 2024.10.31 ——九号公司 2024Q3 业绩点评 业绩持续高增，盈利能力改善 九号公司-WD(689009) 家用电器业[Table_Industry] /可选消费品 | --- | --- | --- | --- | |----------|-------------------------------------|---------------------------|--------------------| | | | | | | | [table_Authors] 蔡雯娟 ( 分析师 ) | 李汉颖 ( 研究助理 ) | 樊夏俐 ( 分析师 ) | | | 021-38031654 | 010-83939833 | 021-38676666 | | | caiwenjuan024354@gtjas.com | lihanying026725@gtjas.com | fanxiali@gtjas.com | | ...

国泰君安版权所有发送给上海东方财富金融数据服务有限公司.东财接收研报邮箱.ybjieshou@eastmoney.com p1 股 票 研 究 粤电力 A 2024 年三季报点评 股票研究 /[Table_Date] 2024.10.31 业绩低于预期，静待广东长协电价落地 粤电力 A(000539) [Table_Industry] 电力/公用事业 | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |----------|-------------------------------------|----------------------------|-------|--------|-------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | [table_Authors] 于鸿光 ( 分析师 ) | 孙辉贤 ( 分析师 ) | | 汪玥 ( | 研究助理 | ) | | | | | | 021-38031730 | 021 ...

股 票 研 究 公 司 更 新 报 告 证 券 研 究 报 告 国泰君安版权所有发送给上海东方财富金融数据服务有限公司.东财接收研报邮箱.ybjieshou@eastmoney.com p1 ——科德数控 2024 年三季报点评 业绩基本符合预期，产能释放助力远期成长 科德数控(688305) [Table_Industry] 资本货物/工业 | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |----------|-------------------------------------|-------|-------|-------|-------|--------|-------|-------|---------------------------| | | | | | | | | | | | | | [table_Authors] 肖群稀 ( 分析师 ) | | | | | 欧阳蕤 | | ( | 分析师 ) | | | 0755-23976830 | | | | | | | | 021-38676550 | | | xiao ...

国泰君安版权所有发送给上海东方财富金融数据服务有限公司.东财接收研报邮箱.ybjieshou@eastmoney.com p1 股 票 研 究 证 券 研 究 报 告 股票研究 /[Table_Date] 2024.10.31 ——中国太保 2024 年三季报业绩点评 价值增长提速，投资回暖增厚利润 中国太保(601601) [Table_Industry] 保险/金融 | --- | --- | --- | |----------|-------------------------------------|-------------------------| | | | | | | [table_Authors] 刘欣琦 ( 分析师 ) | 李嘉木 ( 分析师 ) | | | 021-38676647 | 021-38038619 | | | liuxinqi@gtjas.com | lijiamu026075@gtjas.com | | 登记编号 | S0880515050001 | S0880524030003 | 本报告导读： 公司前三季度归母净利润同比增长 65.5%，主要得益于投资收益提振；寿险 ...

Investment Rating - The report maintains a "Buy" rating for the company, with a target price of 3.35 yuan, down from the previous target of 4.20 yuan [4] Core Views - The company's performance in the first three quarters of 2024 declined significantly due to falling vanadium prices, with revenue dropping by 6.12% YoY to 10.474 billion yuan and net profit attributable to shareholders plummeting by 78.92% YoY to 183 million yuan [9] - Despite the decline in vanadium prices, the company's production remained stable, with vanadium and titanium product output holding steady [2] - The report expects the company's performance to gradually recover as downstream demand improves [2] Financial Performance - The company's net profit attributable to shareholders for Q1-Q3 2024 was 68 million yuan, 69 million yuan, and 46 million yuan respectively, showing a further decline in Q3 [9] - The report revised down the company's net profit forecasts for 2024-2025 to 215 million yuan and 435 million yuan, respectively, and introduced a 2026 forecast of 583 million yuan [9] - The company's EPS for 2024-2026 is expected to be 0.02 yuan, 0.05 yuan, and 0.06 yuan, respectively [9] Production and Sales - In H1 2024, the company sold 25,700 tons of vanadium products, up 6.02% YoY, while titanium slag and titanium dioxide sales were 98,800 tons and 128,600 tons, down 7.13% and 2.35% YoY, respectively [9] - The average selling price of vanadium products in H1 2024 was 83,000 yuan/ton, down 29% YoY, leading to a 25% decline in vanadium product revenue [9] Industry and Market Trends - The oversupply of vanadium products in 2024, driven by declining demand from the rebar sector, has pressured prices and dragged down the company's profits [9] - The titanium sector showed stable profitability, with titanium slag and titanium dioxide revenues increasing by 6.01% and 23.1% YoY in H1 2024, respectively [9] - The vanadium battery industry is steadily developing, with the company supplying over 16,000 tons of high-quality raw materials for vanadium electrolyte production as of Q3 2024 [9] Valuation and Comparables - The company is valued at 2.5x PB for 2024, slightly below the industry average of 2.56x PB, based on comparable companies such as Oriental Tantalum and Huaxi Nonferrous Metals [12][13] - The company's current price is 2.86 yuan, with a 52-week price range of 2.24-3.62 yuan and a market capitalization of 26.584 billion yuan [5]

股 票 研 究 ——古井贡酒 2024 年三季报点评 展现韧性，优势凸显 古井贡酒(000596) 食品饮料 [Table_Industry] /必需消费 | --- | --- | --- | --- | --- | --- | --- | --- | |----------|-----------------------------------|-----------------------|-------|-------|-------|-------|-------| | | | | | | | | | | | [table_Authors] 訾猛 ( 分析师 ) | 李耀 ( 分析师 ) | | | | | | | | 021-38676442 | 021-38675854 | | | | | | | | zimeng@gtjas.com | liyao022899@gtjas.com | | | | | | | 登记编号 | S0880513120002 | S0880520090001 | | | | | | 本报告导读： 2024Q3 公司收入表现符合预期，利润略超预期；得益于费率下行，公司盈 ...

国泰君安版权所有发送给上海东方财富金融数据服务有限公司.东财接收研报邮箱.ybjieshou@eastmoney.com p1 股 票 研 究 ——3Q24 三季度业绩点评 业绩符合预期，利润率持续改善 绝味食品(603517) 食品饮料 [Table_Industry] /必需消费 | --- | --- | --- | --- | --- | --- | |----------|-----------------------------------|---------------------|-------|-------|-------| | | | | | | | | | [table_Authors] 訾猛 ( 分析师 ) | 姚世佳 ( 分析师 ) | | | | | | 021-38676442 | 021-38676912 | | | | | | zimeng@gtjas.com | yaoshijia@gtjas.com | | | | | 登记编号 | S0880513120002 | S0880520070001 | | | | 本报告导读： 业绩符合预期，利润率改善，潜在第二曲线预期催 ...

股 票 研 究 公 司 更 新 报 告 证 券 研 究 报 告 国泰君安版权所有发送给上海东方财富金融数据服务有限公司.东财接收研报邮箱.ybjieshou@eastmoney.com p1 ——华熙生物 2024 三季报点评 组织持续变革，坚持科技驱动 华熙生物(688363) 家庭及个人用品 [Table_Industry] /必需消费 | --- | --- | --- | --- | |----------|-----------------------------------|----------------------|-------------------| | | | | | | | [table_Authors] 訾猛 ( 分析师 ) | 闫清徽 ( 分析师 ) | 杨柳 ( 分析师 ) | | | 021-38676442 | 021-38031651 | 021-38038323 | | | zimeng@gtjas.com | yanqinghui@gtjas.com | yangliu@gtjas.com | | 登记编号 | S0880513120002 | S0880522120 ...